Florida Eye Microsurgical Institute

Boynton Beach, Florida 33426

0 studies enrolling now · 13 studies all time

What they study most

"Wet" Age-Related Macular Degeneration, Blepharitis, Cataracts, Diabetic Macular Edema, Dry Eye Disease, Exudative Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration, Macular Edema, Ocular Comfort, Retinal Vein Occlusion, Wet Age-related Macular Degeneration

Studies at this site

• A Study of NGM621 in Participants With Geographic Atrophy — Completed
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) — Stopped early
• A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. — Stopped early
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) — Completed
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO — Stopped early
• Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD — Completed
• Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions — Completed
• The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period — Completed
• Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase — Completed
• Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome — Completed
• A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration — Stopped early
• A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration — Stopped early